additional navigation

You are here:


Even if a disease is very common, the development of safe and effective medication is very cost-intensive. Thus companies who operate in the generally smaller orphan drug sector have to rely on cooperative and strategic alliances with reliable partners. AOP Orphan has a worldwide network of effective alliances it can resort to in the areas of research, production, and distribution.


AOP Orphan Contact

AOP Orphan Middle East

AOP Orphan worldwide

Products & Area of treatment